269 related articles for article (PubMed ID: 16460044)
21. Cross-linking to an interrupted polypurine sequence with a platinum-modified triplex-forming oligonucleotide.
Campbell MA; Miller PS
J Biol Inorg Chem; 2009 Aug; 14(6):873-81. PubMed ID: 19350290
[TBL] [Abstract][Full Text] [Related]
22. Chemical modification of triplex-forming oligonucleotide to promote pyrimidine motif triplex formation at physiological pH.
Torigoe H; Nakagawa O; Imanishi T; Obika S; Sasaki K
Biochimie; 2012 Apr; 94(4):1032-40. PubMed ID: 22245184
[TBL] [Abstract][Full Text] [Related]
23. Intercalator conjugates of pyrimidine locked nucleic acid-modified triplex-forming oligonucleotides: improving DNA binding properties and reaching cellular activities.
Brunet E; Corgnali M; Perrouault L; Roig V; Asseline U; Sørensen MD; Babu BR; Wengel J; Giovannangeli C
Nucleic Acids Res; 2005; 33(13):4223-34. PubMed ID: 16049028
[TBL] [Abstract][Full Text] [Related]
24. Triplex-induced recombination and repair in the pyrimidine motif.
Kalish JM; Seidman MM; Weeks DL; Glazer PM
Nucleic Acids Res; 2005; 33(11):3492-502. PubMed ID: 15961731
[TBL] [Abstract][Full Text] [Related]
25. Antiparallel polypurine phosphorothioate oligonucleotides form stable triplexes with the rat alpha1(I) collagen gene promoter and inhibit transcription in cultured rat fibroblasts.
Joseph J; Kandala JC; Veerapanane D; Weber KT; Guntaka RV
Nucleic Acids Res; 1997 Jun; 25(11):2182-8. PubMed ID: 9153319
[TBL] [Abstract][Full Text] [Related]
26. Pyrimidine phosphorothioate oligonucleotides form triple-stranded helices and promote transcription inhibition.
Xodo L; Alunni-Fabbroni M; Manzini G; Quadrifoglio F
Nucleic Acids Res; 1994 Aug; 22(16):3322-30. PubMed ID: 8078767
[TBL] [Abstract][Full Text] [Related]
27. Presence of divalent cation is not mandatory for the formation of intramolecular purine-motif triplex containing human c-jun protooncogene target.
Kaushik S; Kaushik M; Svinarchuk F; Malvy C; Fermandjian S; Kukreti S
Biochemistry; 2011 May; 50(19):4132-42. PubMed ID: 21381700
[TBL] [Abstract][Full Text] [Related]
28. Chemical modification of pyrimidine TFOs: effect on i-motif and triple helix formation.
Lacroix L; Mergny JL
Arch Biochem Biophys; 2000 Sep; 381(1):153-63. PubMed ID: 11019831
[TBL] [Abstract][Full Text] [Related]
29. Transcription inhibition induced by modified triple helix-forming oligonucleotides: a quantitative assay for evaluation in cells.
Faria M; Wood CD; White MR; Hélène C; Giovannangeli C
J Mol Biol; 2001 Feb; 306(1):15-24. PubMed ID: 11178890
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of novel TFOs bearing an abasic portion and their triplex forming ability with a DNA duplex containing a pyrimidine-gapped polypurine strand.
Sato M; Moriguchi T; Shinozuka K
Nucleic Acids Res Suppl; 2003; (3):141-2. PubMed ID: 14510420
[TBL] [Abstract][Full Text] [Related]
31. Targeted gene knockout by 2'-O-aminoethyl modified triplex forming oligonucleotides.
Puri N; Majumdar A; Cuenoud B; Natt F; Martin P; Boyd A; Miller PS; Seidman MM
J Biol Chem; 2001 Aug; 276(31):28991-8. PubMed ID: 11389147
[TBL] [Abstract][Full Text] [Related]
32. Targeting the human androgen receptor gene with platinated triplex-forming oligonucleotides.
Graham MK; Brown TR; Miller PS
Biochemistry; 2015 Apr; 54(13):2270-82. PubMed ID: 25768916
[TBL] [Abstract][Full Text] [Related]
33. Effect of DNA target sequence on triplex formation by oligo-2'-deoxy- and 2'-O-methylribonucleotides.
Cassidy RA; Puri N; Miller PS
Nucleic Acids Res; 2003 Jul; 31(14):4099-108. PubMed ID: 12853627
[TBL] [Abstract][Full Text] [Related]
34. A triple-helix forming oligonucleotide targeting genomic DNA fails to induce mutation.
Reshat R; Priestley CC; Gooderham NJ
Mutagenesis; 2012 Nov; 27(6):713-9. PubMed ID: 22914677
[TBL] [Abstract][Full Text] [Related]
35. Stable oligonucleotide-directed triplex formation at target sites with CG interruptions: strong sequence-specific recognition by 2',4'-bridged nucleic-acid-containing 2-pyridones under physiological conditions.
Obika S; Hari Y; Sekiguchi M; Imanishi T
Chemistry; 2002 Oct; 8(20):4796-802. PubMed ID: 12561120
[TBL] [Abstract][Full Text] [Related]
36. Triple helix formation by (G,A)-containing oligonucleotides: asymmetric sequence effect.
Arimondo PB; Barcelo F; Sun JS; Maurizot JC; Garestier T; Hélène C
Biochemistry; 1998 Nov; 37(47):16627-35. PubMed ID: 9843430
[TBL] [Abstract][Full Text] [Related]
37. Selective recognition of pyrimidine motif triplexes by a protein encoded by the bacterial transposon Tn7.
Rao JE; Craig NL
J Mol Biol; 2001 Apr; 307(5):1161-70. PubMed ID: 11292332
[TBL] [Abstract][Full Text] [Related]
38. Targeting DNA with "light-up" pyrimidine triple-helical forming oligonucleotides conjugated to stabilizing fluorophores (LU-TFOs).
Renard BL; Lartia R; Asseline U
Org Biomol Chem; 2008 Dec; 6(23):4413-25. PubMed ID: 19005602
[TBL] [Abstract][Full Text] [Related]
39. Triplex formation by a psoralen-conjugated oligodeoxyribonucleotide containing the base analog 8-oxo-adenine.
Miller PS; Bi G; Kipp SA; Fok V; DeLong RK
Nucleic Acids Res; 1996 Feb; 24(4):730-6. PubMed ID: 8604317
[TBL] [Abstract][Full Text] [Related]
40. (A,G)-oligonucleotides form extraordinary stable triple helices with a critical R.Y sequence of the murine c-Ki-ras promoter and inhibit transcription in transfected NIH 3T3 cells.
Alunni-Fabbroni M; Pirulli D; Manzini G; Xodo LE
Biochemistry; 1996 Dec; 35(50):16361-9. PubMed ID: 8973212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
